Spyre Therapeutics
SYRE
#2800
Rank
โ‚ฌ5.26 B
Marketcap
61,69ย โ‚ฌ
Share price
4.75%
Change (1 day)
460.52%
Change (1 year)

Annual Reports (10-K)

Latest form 10-K annual reports for Spyre Therapeutics CIK: 0001636282

Thumbnail Spyre Therapeutics 10-K Annual Report

10-K Annual Report 2026-02-19

Language: English

View Annual Report (10-K)
Thumbnail Spyre Therapeutics 10-K Annual Report

10-K Annual Report 2025-02-27

Language: English

View Annual Report (10-K)
Thumbnail Spyre Therapeutics 10-K Annual Report 2023

10-K Annual Report 2023

Language: English

View Annual Report (10-K)
Thumbnail Spyre Therapeutics 10-K Annual Report 2022

10-K Annual Report 2022

Language: English

View Annual Report (10-K)
Thumbnail Spyre Therapeutics 10-K Annual Report

10-K Annual Report 2022-03-08

Language: English

View Annual Report (10-K)
Thumbnail Spyre Therapeutics 10-K Annual Report

10-K Annual Report 2021-03-18

Language: English

View Annual Report (10-K)
Thumbnail Spyre Therapeutics 10-K Annual Report 2019

10-K Annual Report 2019

Language: English

View Annual Report (10-K)
Thumbnail Spyre Therapeutics 10-K Annual Report 2018

10-K Annual Report 2018

Language: English

View Annual Report (10-K)
Thumbnail Spyre Therapeutics 10-K Annual Report 2017

10-K Annual Report 2017

Language: English

View Annual Report (10-K)
Thumbnail Spyre Therapeutics 10-K Annual Report 2016

10-K Annual Report 2016

Language: English

View Annual Report (10-K)